|
JRC Publications Repository >
Browsing by Author BRUCHERTSEIFER Frank
Showing results 4 to 23 of 60
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type | | 2012 | Alpha particles and induction of an anti-tumour immune response | GORIN J; GOUARD S.; CHEREL M.; FAIVRE-CHAUVET A; MENAGER J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DAVODEAU F; GASCHET J | Contributions to Conferences |
| 2011 | An Alpha-Particle Emiting Radiopeptide (213 Bi-DOTA-PESIN) for Therapy of Prostate Cancer | WILD D.; FRISCHKNECHT M.; ZHANG H.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; BOISCLAIR J.; PROVENCHER-BOLLIGER A.; REUBI Jean-Claude; MAECKE H. R. | Articles in Journals |
| 2013 | Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation | WULBRAND Christian; SEIDL C.; GAERTNER F. C.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2010 | [An(H2O)9](CF3SO3)3 (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory | APOSTOLIDIS Christos; SCHIMMELPFENNIG Bernd; MAGNANI Nicola; LINDQVIST-REIS Patric; WALTER Olaf; SYKORA Richard; MORGENSTERN Alfred; COLINEAU Eric; CACIUFFO Roberto; KLENZE R., et al | Articles in Journals |
| 2009 | Analysis of DNA double-strand breaks in gastric cancer cells after treatment with 213Bi-immunoconjugates | SEIDL C.; FRANK Annette; PFOST B.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE Reingard | Contributions to Conferences |
| 2011 | Analysis of Patient Survival in a Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma | ALLEN B. J.; SINGLA A; RAJA C.; RIZVI S.; GRAHAM P.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN Alfred | Articles in Journals |
| 2012 | Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes | MORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos | Articles in Journals |
| 2008 | Bismuth-213 Radioimmunotherapy with C595 Anti¿MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model | SONG E.; QU C. F.; RIZVI S.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; PERKINS A. D. | Articles in Journals |
| 2012 | Combined 213Bi-DTPA- F3 and paclitaxel treatment of peritoneal spread of human ovarian carcinoma in a mouse model enhances therapeutic efficacy due to enhanced induction of apoptosis and G2/M phase cell-cycle arrest | SEIDL C.; VALLON M.; BLECHERT B.; GILBERTZ K.-P.; AICHLER M; FEUCHTINGER A; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M. | Contributions to Conferences |
| 2012 | Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model | GUSTAFSSON Anna; BAECK Tom; ELGQVIST Joergen; JACOBSSON Lars; HULTBORN Ragnar; ALBERTSSON Per; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; JENSEN Holger; LINDEGREN Sture | Articles in Journals |
| 2009 | Cross Sections of the Reaction 231Pa(d,3n)230U for Production of 230U/226Th for Targeted Alpha Therapy | MORGENSTERN Alfred; LEBEDA O.; STURSA J.; CAPOTE R.; SIN M.; BRUCHERTSEIFER Frank; ZIELINSKA Barbara; APOSTOLIDIS Christos | Articles in Journals |
| 2008 | Cross-sections of the Reaction 232Th(p,3n)230Pa for Production of 230U for Targeted Alpha Therapy | MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; CAPOTE R.; GOUDER Thomas; SIMONELLI Federica; SIN M.; ABBAS Kamel | Articles in Journals |
| 2013 | Decay data measurements on 213Bi using recoil atoms | MAROULI MARIA; SULIMAN GABRIEL; POMME Stefaan; VAN AMMEL Raf; JOBBAGY VIKTOR; STROH HEIKO; DIKMEN H.; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank, et al | Articles in Journals |
| 2008 | Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian Cancer | KNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C. | Articles in Journals |
| 2013 | Die Alpha-Emitter Radioimmuntherapie des multiplen Myeloms mit 213Bi-CHX-A“-DTPA-anti-CD38 Immunkonjugaten zeigt eine hohe Effizienz im präklinischen Xenograft-Modell | TEILUF K; SEIDL C.; BLECHERT B.; GÄRTNER Florian; GILBERTZ K.-P.; FERNANDEZ V; BASSERMANN F; ENDELL J; BOXHAMMER R; AICHLER M, et al | Contributions to Conferences |
| 2012 | Die intravesikale Radioimmuntherapie mit Bi-213-anti-EGFR Immunkonjugaten verursacht keine Schäden am Urothel | MÜLLER Felix; SEIDL C.; WEIRICH G; RÖTZER S; FAZEL J; FRANK Annette; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SENEKOWITSCH-SCHMIDTKE R. | Contributions to Conferences |
| 2010 | Differential Gene Expression Triggered by Highly Cytotoxic a- Emitter-immunoconjugates in Gastric Cancer Cells | SEIDL C.; PORT M.; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.; ABEND M. | Articles in Journals |
| 2012 | Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest | VALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank, et al | Articles in Journals |
| 2012 | Feasibility of 99Mo production by proton-induced fission of 232Th | ABBAS Kamel; HOLZWARTH Uwe; SIMONELLI Federica; KOZEMPEL JAN; CYDZIK Izabela; BULGHERONI A.; COTOGNO Giulio; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; MORGENSTERN Alfred | Articles in Journals |
| 2010 | A feasibility study of a new method for production of U-230/TH-226 fro alpha-immunotherapy applications | ABBAS Kamel; SIMONELLI Federica; CYDZIK Izabela; KOZEMPEL JAN; APOSTOLIDIS Christos; ZIELINSKA Barbara; BRUCHERTSEIFER Frank; MORGENSTERN Alfred | Contributions to Conferences |
Showing results 4 to 23 of 60
|
